Log on / register
Feedback | Support | My details
Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury.
Failla M, Genovese T, Mazzon E, Gili E, Muià C, Sortino M, Crimi N, Caputi AP, Cuzzocrea S, Vancheri C
Respir Res 2006, 7:137
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Cyclooxygenase-2 deficiency exacerbates bleomycin-induced lung dysfunction but not fibrosis.
Card JW, Voltz JW, Carey MA, Bradbury JA, Degraff LM, Lih FB, Bonner JC, Morgan DL, Flake GP, Zeldin DC
Am J Respir Cell Mol Biol 2007 Sep, 37:300-8
 [PubMed Central] [PubMed] [Related articles]
2.
Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?
Huang SK, Peters-Golden M
Chest 2008 Jun, 133:1442-50
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.